301 related articles for article (PubMed ID: 3889056)
1. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.
Cavallo-Perin P; Cassader M; Bozzo C; Bruno A; Nuccio P; Dall'Omo AM; Marucci M; Pagano G
J Clin Invest; 1985 May; 75(5):1659-65. PubMed ID: 3889056
[TBL] [Abstract][Full Text] [Related]
2. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
[TBL] [Abstract][Full Text] [Related]
3. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.
Rizza RA; Mandarino LJ; Gerich JE
J Clin Endocrinol Metab; 1982 Jan; 54(1):131-8. PubMed ID: 7033265
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of insulin resistance in aging.
Fink RI; Kolterman OG; Griffin J; Olefsky JM
J Clin Invest; 1983 Jun; 71(6):1523-35. PubMed ID: 6345584
[TBL] [Abstract][Full Text] [Related]
5. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
Petrides AS; Groop LC; Riely CA; DeFronzo RA
J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman OG; Insel J; Saekow M; Olefsky JM
J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt.
Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Fronda GR; Avagnina P; Molino G; Bozzo C; Pagano G
Acta Endocrinol (Copenh); 1986 Jul; 112(3):377-82. PubMed ID: 3529784
[TBL] [Abstract][Full Text] [Related]
8. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus.
Scarlett JA; Kolterman OG; Ciaraldi TP; Kao M; Olefsky JM
J Clin Endocrinol Metab; 1983 Jun; 56(6):1195-201. PubMed ID: 6341390
[TBL] [Abstract][Full Text] [Related]
9. Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects.
Rodnick KJ; Haskell WL; Swislocki AL; Foley JE; Reaven GM
Am J Physiol; 1987 Nov; 253(5 Pt 1):E489-95. PubMed ID: 3318492
[TBL] [Abstract][Full Text] [Related]
10. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the insulin resistance of aging.
Rowe JW; Minaker KL; Pallotta JA; Flier JS
J Clin Invest; 1983 Jun; 71(6):1581-7. PubMed ID: 6345585
[TBL] [Abstract][Full Text] [Related]
12. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
[TBL] [Abstract][Full Text] [Related]
13. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
14. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
15. [Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
Vetter D; Fratte S; Winiszewski P; Reville M; Hirsch E; Roze F; Blickle JF; Pinget M; Doffoel M; Bockel R
Gastroenterol Clin Biol; 1990; 14(5):483-91. PubMed ID: 2194890
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in essential hypertension.
Ferrannini E; Buzzigoli G; Bonadonna R; Giorico MA; Oleggini M; Graziadei L; Pedrinelli R; Brandi L; Bevilacqua S
N Engl J Med; 1987 Aug; 317(6):350-7. PubMed ID: 3299096
[TBL] [Abstract][Full Text] [Related]
17. Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.
Pisu E; Lombardi A; De Benedictis D; Bozzo C; Chiara E; Baggiore C; Bruno A; Cravero L; Pagano G; Lenti G
Acta Diabetol Lat; 1986; 23(3):215-25. PubMed ID: 3538736
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of the carbohydrate intolerance of cirrhosis.
Proietto J; Alford FP; Dudley FJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.
Fantus IG; Brosseau R
J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of insulin receptors in postnecrotic cirrhosis of liver.
Teng CS; Ho PW; Yeung RT
J Clin Endocrinol Metab; 1982 Sep; 55(3):524-30. PubMed ID: 6284782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
